Literature DB >> 6870224

Intranasal administration of gentamicin in human subjects.

A Rubinstein.   

Abstract

The effectiveness of gentamicin administered by the intranasal route in healthy human volunteers was studied. Thirty minutes after gentamicin in a solution of 1% sodium glycocholate was administered at 2 mg/kg of body weight, gentamicin concentrations of 2.48 +/- 0.42 mg/ml were present in the sera. Serum concentrations decreased to 0.94 +/- 0.13 mg/ml at 180 min. No serious side effects were observed. There was slight local irritation after a single dose. When administered intranasally without glycocholate, gentamicin was not present in the sera in detectable amounts.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6870224      PMCID: PMC184815          DOI: 10.1128/AAC.23.5.778

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  New hydrophilic vehicle enabling rectal and vaginal absorption of insulin, heparin, phenol red and gentamicin.

Authors:  E Touitou; M Donbrow; E Azaz
Journal:  J Pharm Pharmacol       Date:  1978-10       Impact factor: 3.765

Review 2.  Mechanisms of surfactant effects on drug absorption.

Authors:  M Gibaldi; S Feldman
Journal:  J Pharm Sci       Date:  1970-05       Impact factor: 3.534

3.  Increase of the intestinal absorption of gentamicin and amikacin by a nonionic surfactant.

Authors:  A Rubinstein; E Rubinstein; E Toitou; M Donbrow
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

4.  Rapid microassay of gentamicin, kanamycin, neomycin, streptomycin, and vancomycin in serum or plasma.

Authors:  L D Sabath; J I Casey; P A Ruch; L L Stumpf; M Finland
Journal:  J Lab Clin Med       Date:  1971-09

5.  Effective intestinal absorption of insulin in diabetic rats using a new formulation approach.

Authors:  E Touitou; M Donbrow; A Rubinstein
Journal:  J Pharm Pharmacol       Date:  1980-02       Impact factor: 3.765

6.  Insulin given intranasally induces hypoglycaemia in normal and diabetic subjects.

Authors:  A E Pontiroli; M Alberetto; A Secchi; G Dossi; I Bosi; G Pozza
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-30
  6 in total
  2 in total

1.  A semisynthetic Quillaja saponin as a drug delivery agent for aminoglycoside antibiotics.

Authors:  J Recchia; M H Lurantos; J A Amsden; J Storey; C R Kensil
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

2.  Nasal dermoplasty for recurrent polyps in a patient with churg-strauss syndrome.

Authors:  George Anastasopoulos; Theophanis Machas; Sofia Kegioglou; Demetra Rapti
Journal:  Case Rep Otolaryngol       Date:  2015-01-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.